Depression News and Research

Latest Depression News and Research

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

T.S. Wiley to lecture on the latest advances in anti-aging medicine

Wiley Systems™, Inc. announces that internationally acclaimed Author T.S. Wiley will be lecturing at the second annual European Congress on Anti-Aging & Aesthetic Medicine (ECAAAM) at the Congress Centre, Mainz, near Frankfurt, October 15-17, 2009. Wiley will give two lectures among other international experts presenting the latest advances in anti-aging medicine.

14 Oct 2009

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

A new neurosurgical procedure may prove helpful for patients with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was found generally safe and provided significant improvement of depressive symptoms in a small group of patients, according to lead researcher Ziad Nahas, M.D. at the Medical University of South Carolina. The data are reported in the on-line issue of Biological Psychiatry.

14 Oct 2009

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

AVANIR Pharmaceuticals, Inc. today announced detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS).

14 Oct 2009

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

13 Oct 2009

9% of Québec adults report being diagnosed with a thyroid disease

New research reveals 9 percent of Québec adults report being diagnosed with a thyroid disease. The thyroid gland produces the hormones that regulate our growth, maturation, speed of metabolism and sensitivity to other hormones.

13 Oct 2009

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

A Stanford University School of Medicine researcher has pinpointed the mechanism by which a gene associated with both autism and schizophrenia influences behavior in mice. And just recently, he received a $1.65 million government grant to expand his efforts to include many more such genes.

13 Oct 2009

Report shows that visual impairments are associated with the risk of death in older adults

Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Women abused by intimate partners suffer higher rates of medical maladies

Women abused by intimate partners suffer higher rates of a wide variety of doctor-diagnosed medical maladies compared to women who were never abused, according to a new study of more than 3,000 women.

13 Oct 2009

Little Company of Mary Hospital and Health Care Centers to complete Campus Transformation Project

The Board of Directors at Little Company of Mary Hospital and Health Care Centers voted to proceed with the completion of the Campus Transformation Project. Little Company of Mary obtained the Certificate of Need (CON) last spring, making it the boldest construction project since the Sisters opened the original hospital in the midst of the Great Depression - 80 years ago this January. It will create the Southwest Chicago area's first all-private room, private bath acute care hospital that includes a beautiful new Women's Center for Life and Health.

13 Oct 2009

A new site and blog for dieters to share information launched by DietReality.com

In response to an increasing need to provide up-to-date information on safe and effective weight loss products, DietReality.com has launched a new site and blog designed to empower dieters to share information.

12 Oct 2009

CED to host popular STREAK program

CED, formerly the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit organization that promotes entrepreneurial efforts in the Triangle region of North Carolina, has announced that it will host the next installment of its popular STREAK program, to be held Thursday, Oct. 8 from 3 p.m. to 5 p.m.

12 Oct 2009

WCMC-Q program highlights the importance of mental health to overall physical health

Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.

12 Oct 2009

Web-based TV program to focus on holistic lifestyle

The outcome of the current healthcare legislation is uncertain, but one matter is clear: Americans need to get healthier. From childhood obesity to alarming rates of clinical depression among adults, people across the U.S. have been confronted with the consequences of lives off-balance.

9 Oct 2009

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo

9 Oct 2009

New soy germ-based ingredient improves menopausal symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

9 Oct 2009

Short, frequent bouts of lower intensity exercise can improve body image

Attention weekend warriors: the simple act of exercise and not fitness itself can convince you that you look better, a new University of Florida study finds.

9 Oct 2009

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

8 Oct 2009

Clinical and health status outcomes information repository of heart attack patients completed

An important observational registry evaluating processes of care and one-year outcomes of over 4300 heart attack patients is now being completed. Researchers at the Saint Luke's Mid America Heart Institute in Kansas City, MO have led this observational research study in collaboration with 23 other hospitals throughout the U.S.

8 Oct 2009

DoD funds Screening for Mental Health's awareness program for military personnel

Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.

8 Oct 2009

Depression News and Research

Latest Depression News and Research

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

T.S. Wiley to lecture on the latest advances in anti-aging medicine

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

9% of Québec adults report being diagnosed with a thyroid disease

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

Report shows that visual impairments are associated with the risk of death in older adults

Women abused by intimate partners suffer higher rates of medical maladies

Little Company of Mary Hospital and Health Care Centers to complete Campus Transformation Project

A new site and blog for dieters to share information launched by DietReality.com

CED to host popular STREAK program

WCMC-Q program highlights the importance of mental health to overall physical health

Web-based TV program to focus on holistic lifestyle

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

New soy germ-based ingredient improves menopausal symptoms

Short, frequent bouts of lower intensity exercise can improve body image

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Clinical and health status outcomes information repository of heart attack patients completed

DoD funds Screening for Mental Health's awareness program for military personnel

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in